Peptide Molecular Weight, Sequences and CAS Numbers

What do peptide molecular weight, sequence and CAS number mean?

Peptide molecular weight is the calculated or measured mass of a peptide molecule, usually reported in daltons or grams per mole. The peptide sequence describes the order of amino acids from the N-terminus to the C-terminus, while a CAS number is a registry identifier assigned to a specific chemical substance.

Researchers use these identifiers together because none of them is sufficient on its own. A sequence may omit salt form or terminal modification, a molecular weight may vary depending on calculation method, and a CAS number may refer to a particular stereochemical or chemical form rather than every material sold under a common name.

This article focuses on analytical and documentation concepts relevant to research-grade peptides. It does not evaluate any product for human use, safety, effectiveness or regulatory status.

Research Notice
This article discusses published scientific research. It is provided for educational purposes only and does not provide medical advice, dosing, administration or human-use instructions.

1. Peptide molecular weight and why values differ

Peptide molecular weight is based on the sum of the amino acid residues plus the terminal groups and any modifications. In peptide chemistry, a residue is the amino acid unit after peptide-bond formation, which means water has been lost during condensation.

Two common values appear in catalogues, certificates of analysis and databases: average molecular weight and monoisotopic molecular weight. Average molecular weight reflects naturally occurring isotope abundance, while monoisotopic mass uses the most abundant isotope of each element and is often relevant to high-resolution mass spectrometry.

A discrepancy of a few daltons can be meaningful or harmless depending on context. For example, N-terminal acetylation, C-terminal amidation, oxidation, metal coordination, disulfide formation, counterions and hydration can all alter the reported mass.

Salt form is a frequent source of confusion. A peptide may be listed as the free base, acetate salt, trifluoroacetate salt or hydrochloride salt, and these forms do not necessarily have the same formula weight. Analytical reports may therefore distinguish between the mass of the peptide ion and the total material including counterions or residual solvent.

Mass spectrometry provides experimental evidence for molecular mass as an established analytical chemistry method, not a biological efficacy claim. It can confirm whether the observed mass is consistent with the proposed structure, but it does not by itself establish purity, identity under every condition, biological activity or suitability for any human application.

2. Peptide sequences and notation conventions

Peptide sequences are normally written from the N-terminus, the end with a free or modified amino group, to the C-terminus, the end with a free or modified carboxyl group. This direction matters because reversing the order creates a different molecule even when the same amino acids are present.

Sequences may be written in one-letter or three-letter amino acid code. For example, glycine is G or Gly, histidine is H or His, and lysine is K or Lys. Three-letter notation is often clearer when a sequence includes non-standard residues, D-amino acids or terminal modifications.

Stereochemistry is a critical detail. Most ribosomally produced peptides contain L-amino acids, but synthetic peptides may include D-amino acids, beta-amino acids or other non-canonical residues. A CAS number or molecular formula may not be enough to reveal stereochemical differences unless the underlying record is checked carefully.

Terminal modifications should be written explicitly. Common examples include Ac- for N-terminal acetylation and -NH2 for C-terminal amidation. Disulfide bridges, cyclization, lipidation, glycosylation and metal complexes should also be specified because they change chemical identity and analytical behaviour.

Sequence information is a structural claim supported by chemical synthesis records and analytical characterization rather than by in vitro, animal or human outcome evidence. When biological findings are discussed in the scientific literature, their evidence level should be stated separately from the chemistry of the peptide itself.

3. CAS numbers in peptide identification

A CAS Registry Number is a numerical identifier assigned by Chemical Abstracts Service to a chemical substance. It is useful for database searching, procurement documentation and distinguishing substances with similar names.

CAS numbers are not quality ratings. They do not certify purity, confirm analytical performance, establish regulatory authorization or show that two materials from different sources are equivalent. They are identifiers, not proof of suitability for any particular experiment.

For peptides, CAS number interpretation can be complicated. One identifier may correspond to a specific sequence and modification state, while another may refer to a salt, hydrate, stereoisomer, complex or mixture. Some newer, proprietary or highly modified peptides may be inconsistently represented across secondary databases.

Researchers should treat CAS numbers as one component of identity verification. The strongest documentation usually aligns the CAS number, full sequence, molecular formula, calculated mass, observed mass, purity method and lot-specific analytical results.

This is an evidence documentation issue, not a therapeutic evidence issue. A CAS match does not translate in vitro findings, animal data, observational human data, controlled human trials or authorised clinical use from one material to another without appropriate comparability evidence.

4. Connecting molecular weight, sequence and analytical data

A practical review starts by matching the written sequence to the calculated molecular weight. Researchers should confirm whether the stated value includes terminal modifications, salts, water, counterions, metal ions or protecting-group remnants.

The next step is comparing calculated mass with observed mass from mass spectrometry. Electrospray ionization and MALDI methods may report charged species, adducts or fragments, so the raw spectrum and interpretation should be considered alongside the final stated molecular weight.

High-performance liquid chromatography is commonly used to estimate purity under defined analytical conditions. HPLC purity is method-dependent and does not identify every impurity, but it can provide useful lot-level information when combined with mass spectrometry and, where relevant, amino acid analysis or NMR.

Researchers working with modified peptides should pay close attention to notation. A peptide with a disulfide bond, an amidated C-terminus or a metal-bound form may have a different analytical profile from the unmodified linear sequence.

These analytical methods are established laboratory techniques. They support identity and composition assessment but do not establish human safety, clinical effect, disease relevance or authorization for any product.

5. Common documentation problems in peptide records

One common problem is a mismatch between common name and sequence. Short peptide names, abbreviations and research nicknames are not always unique, so the full sequence should be treated as the primary structural descriptor.

Another issue is incomplete modification detail. A record that lists only amino acid order may leave out amidation, acetylation, D-residues, cyclization or salt form. These omissions can affect calculated mass, solubility testing, chromatographic retention and interpretation of analytical reports.

CAS number conflicts may occur when secondary databases copy incomplete information or when different forms of a molecule are grouped informally. In formal documentation, researchers should avoid assuming that a CAS number for one salt or stereochemical form applies to another.

Lot-specific certificates of analysis should be read as analytical documents, not as general scientific proof. A certificate can report test results for a particular lot under stated methods, but it does not establish therapeutic performance or equivalence to a pharmaceutical product.

What Does the Research Show?

The evidence relevant to peptide identifiers is mainly chemical and analytical rather than clinical. Published analytical chemistry, pharmacopoeial methods, regulatory guidance and peer-reviewed peptide characterization studies support the use of sequence, molecular mass, chromatography and registry identifiers for substance description.

In vitro evidence: Cell-based or biochemical studies may investigate a peptide molecule, but those findings do not verify a supplier product unless the tested material is specifically characterized and comparable.
Animal evidence: Animal studies can describe experimental effects of a defined molecule in a model, but they do not establish human outcomes or product suitability.
Observational human evidence: Observational reports can identify associations but cannot confirm identity, quality or causation for research materials.
Controlled human trial evidence: Trials may apply to a defined investigational or pharmaceutical preparation and should not be generalized to unrelated research-grade materials.
Established authorised clinical use: Some peptide-based medicines have authorised clinical uses, but that status applies to specific approved products and does not establish the status, safety or effectiveness of similarly named research products.

For laboratory work, the most reliable approach is to align chemical identity records with lot-specific analytical data. Molecular weight, sequence and CAS number are complementary tools, and their limitations should be documented before comparing experimental results across sources.

Related Research Product

The Lux Peptides catalog includes GHK-Cu, a peptide entry whose name illustrates why researchers check whether a record describes a free peptide, a metal complex or another specified form.

Educational Disclaimer
This article is provided for scientific and educational purposes only. It does not describe or imply the safety, effectiveness or intended use of any Lux Peptides product.
Nothing in this article is intended to diagnose, treat, cure or prevent disease or provide instructions for human use.